Zero-COVID policy draws praise
China’s effective strategy to contain contagious variant sweeping the world gains global recognition
China will continue its zeroCOVID-19 policy, which has proved effective and is gaining wider international recognition amid the emergence of the Omicron variant, officials and experts say.
The nation has seen over 40 locally transmitted outbreaks since bringing COVID-19 under control throughout Hubei province and in its capital, Wuhan. These outbreaks were caused by imported infections, health authorities said.
Liang Wannian, head of the National Health Commission’s COVID-19 leading task force, said China adopted the “dynamic zero-infections policy” in August.
“Under the overarching goal of preventing imported infections and domestic flare-ups, this policy means that when a new local outbreak occurs, measures will be taken to promptly stem the spread of the virus and clear new infections,” he told China Daily.
“This approach is the best option and the guiding principle of China’s disease control work. We must resolutely adhere to the policy and protect the health and safety of the population as the top priority.”
Wu Zunyou, chief epidemiologist at the Chinese Center for Disease Control and Prevention, said the strategy of swiftly dealing with new outbreaks can protect most regions of China against COVID-19 and ensure that people live normal lives and production continues.
“This policy has had significant results,” he said. “Most regions on the Chinese mainland are free of COVID-19 infections, and new cases are either detected among incoming passengers or brought in by cargo from overseas.”
In late November, Wu forecast that as the virus rampaged across the world, without these stringent measures China would have experienced some 47.8 million infections and 950,000 related deaths if national rates were on par with the global average.
As the Omicron variant rapidly spreads, prompting many countries to reimpose border closures and travel curbs, experts said China’s success has become even more evident.
Huang Yanzhong, a senior fellow for global health at the New Yorkbased Council on Foreign Relations, told Bloomberg the Omicron variant was a “booster shot” for the zeroCOVID policy, adding that efforts by some Western countries to reinstate COVID-19 restrictions have undermined their claims that China’s approach is not sustainable.
Renowned scholar Martin Jacques from the United Kingdom, a former senior fellow at Cambridge University’s Department of Politics and International Studies, said on Twitter that Western nations, despite their dismal performances in dealing with COVID-19, are questioning China’s effective work.
“Omicron arrives. Up go the restrictions. Panic stations. And China is sitting pretty. When will they learn — from China,” he posted in late November.
A common misconception of China’s virus control strategy is that it aims at achieving zero infections.
Liang, from the National Health Commission, said, “Currently, we are not capable of ensuring there will be no more new domestically transmitted infections, but we are capable and confident of stamping out local infection clusters as quickly as possible.
“A dynamic zero-COVID strategy means not letting the pandemic spiral out of control, but actively controlling it. This strategy meant we had to take prompt and precise action.”
Liang said the first line of defense is implementing pre-departure prevention measures targeting overseas travelers to China — placing arrivals under “close-loop management” as they enter the country. Measures to prevent transmission via objects should also be taken.
Wen Xiaoqing, an official with Tianjin’s health commission, said local authorities have seamless procedures for handling overseas passengers.
“Our measures start right after an international flight lands in Tianjin — from checking passengers’ health codes, temperatures and vaccination history, to conducting epidemiological investigation,” he said.
“People with symptoms such as fever or respiratory illnesses are transferred by special vehicles to designated hospitals, where they are isolated for further diagnosis and treatment. We also thoroughly disinfect all areas they pass through.”
Wu Hao, a national-level disease control expert and public health professor at Capital Medical University in Beijing, said the fact that the
mainland’s first Omicron infection was detected in a centralized isolation area is evidence of the effectiveness of China’s monitoring system.
Liang said increased surveillance measures, especially at fever clinics, along with additional nucleic acid testing capacity and constant screening for mutation, are also key to China containing COVID-19.
In July and August, some 10 rounds of mass testing were carried out in Yangzhou, Jiangsu province, to handle a local outbreak.
Wu Feng, head of the intensive care unit at the Affiliated Hospital of Yangzhou University, told a news briefing that because the novel coronavirus has an incubation period and is transmitted “stealthily”, it is extremely difficult to detect all infections at the same time.
“As a result, even when the majority of residents test negative for the virus in earlier rounds of mass testing, it is necessary to launch more tests at the right moment,” he said.
Last month, when Manzhouli, Inner Mongolia autonomous region, experienced a local outbreak, the city’s testing capacity stood at some 12,000 samples per day.
Guo Yanhong, an official at the National Health Commission’s medical supervision and administration bureau, said that by sending medical assistance teams and mobile testing facilities to Manzhouli, as well as involving local third-party institutions, the city’s daily testing capacity
quickly rose to 152,000 samples.
Guo said that by last month, 30 million samples could be processed daily nationwide.
“Also, to lessen the public’s financial burden, most provincial-level regions have lowered the cost of a test per person to less than 40 yuan ($6.30) and to under 10 yuan for group tests,” she said.
Liang said, “We have accumulated a complete and science-based tool kit to tackle the disease, including widespread nucleic acid tests, the ability to trace close contacts, deliver treatment, mobilize local communities, and ensure normal transportation and livelihoods.
“It is not a single measure or strategy that works, but a combination of multiple factors — for instance, an altruistic spirit, as well as coordination between government departments.”
With China’s increasing efficiency in tackling imported infections and local outbreaks, more emphasis has been placed on striking a balance between disease control requests and enabling people to live normal lives.
Ma Xiaowei, minister of the National Health Commission, told Xinhua News Agency, “Virus control work should be precise and considerate, and local authorities should provide a range of supportive policies to reduce the impact on people’s lives and production, and achieve the best results at the lowest possible social cost.”
The introduction of buffer zones in several border and port areas is an example of such efforts, authorities said.
Liang said, “Villages in a port city where buffer zones are established can adopt stricter measures, including setting up checkpoints and imposing restrictions on people’s movements, while the remaining areas of the city only need to impose regular disease control measures.
“In the buffer zones, regular activities can take place when there are no new cases, but regular screening and health monitoring will be performed.”
Authorities in Ruili, Yunnan province, pioneered this approach, given its long border with Myanmar.
Last year, the city experienced 42 local infection clusters triggered by imported infections, disrupting the once-booming jade trade.
Liang said, “Establishing buffer zones can provide an additional barrier to protect against the virus being imported.”
On Dec 19, Ruili authorities said offline jade vendors outside strictly regulated zones could resume business.
Zhang Guizhen, who owns a local jade business, said: “On hearing this, I began tidying up my shop, preparing hand sanitizers, disinfectant and thermometers. It was great news for jade vendors.”
In October, a local outbreak was reported in Ejine Banner, Inner Mongolia, during the peak autumn tourist season. Local authorities said over 9,000 visitors were stranded in the area.
To ensure their health and safety as they return home, authorities drew up plans for rail passengers, individual travelers, motorists and bus riders.
Xu Xiuzhen, a traveler from Shanghai, said on the train home, “Even though we were stranded, we were treated warmly, with the local authorities providing us with sufficient protective equipment, medical products and food.”
With the development of vaccines and promising drugs to treat COVID-19, experts are discussing a possible end to the pandemic.
Prominent respiratory expert Zhong Nanshan said that before China returns to pre-pandemic life, the global death rate from COVID-19 should fall to about 0.1 percent. Last month, this rate was estimated to be around 1-2 percent.
Additionally, the virus’ basic reproduction rate, also known as R0, should be maintained at about 1-1.5, Zhong said. The reproduction rate for the Delta variant — the dominant strain worldwide — is estimated to fall between 5 and 8.
To achieve such goals, Zhong said China should expand vaccination coverage, enforce regular disease control measures at the community level, and develop effective therapeutics.
By Jan 7, more than 2.9 billion COVID-19 vaccine doses had been administered on the mainland, according to the National Health Commission.
Zhang Boli, an academician at the Chinese Academy of Engineering and a leading traditional Chinese medicine expert, said the pandemic would likely stabilize in spring, when China might ease control policies.
“However, opening up completely will depend on the global situation, especially outbreaks in some African countries where the average vaccination rate is only about 10 percent,” he said.